Found: 45
Select item for more details and to access through your institution.
Predictive capacity of immune‐related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cam4.7370
- By:
- Publication type:
- Article
Effect of preoperative programmed death‐1 or programmed death ligand‐1 immune check point inhibition on complications after surgery for primary head and neck cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 6, p. 863, doi. 10.1002/cncr.35045
- By:
- Publication type:
- Article
CD8+ and FoxP3+ T‐Cell Cellular Density and Spatial Distribution After Programmed Death‐Ligand 1 Check Point Inhibition.
- Published in:
- Laryngoscope, 2023, v. 133, n. 8, p. 1875, doi. 10.1002/lary.30389
- By:
- Publication type:
- Article
Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1202, doi. 10.3390/cancers14051202
- By:
- Publication type:
- Article
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 313, doi. 10.1016/j.cllc.2021.02.009
- By:
- Publication type:
- Article
Preoperative Immunotherapy in the Multidisciplinary Management of Oral Cavity Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682075
- By:
- Publication type:
- Article
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.566315
- By:
- Publication type:
- Article
Validation of brief symptom indexes among patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A trial of the ECOG‐ACRIN Cancer Research Group (E1302).
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8884, doi. 10.1002/cam4.3506
- By:
- Publication type:
- Article
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Laryngeal Preservation Strategies in Locally Advanced Laryngeal and Hypopharyngeal Cancers.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00419
- By:
- Publication type:
- Article
Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00122
- By:
- Publication type:
- Article
Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Induced Bias Due to Crossover Within Randomized Controlled Trials in Surgical Oncology: A Meta-regression Analysis of Minimally Invasive versus Open Surgery for the Treatment of Gastrointestinal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 1, p. 221, doi. 10.1245/s10434-017-6210-y
- By:
- Publication type:
- Article
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00072
- By:
- Publication type:
- Article
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2016, v. 38, n. 12, p. 1759, doi. 10.1002/hed.24501
- By:
- Publication type:
- Article
p53-Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 1, p. 148, doi. 10.1016/j.molonc.2015.09.004
- By:
- Publication type:
- Article
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.
- Published in:
- Head & Neck, 2015, v. 37, n. 11, p. 1665, doi. 10.1002/hed.23813
- By:
- Publication type:
- Article
Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partners.
- Published in:
- Head & Neck, 2015, v. 37, n. 9, p. 1282, doi. 10.1002/hed.23760
- By:
- Publication type:
- Article
Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): A trial of the Eastern Cooperative Oncology Group
- Published in:
- Head & Neck, 2013, v. 35, n. 7, p. 942, doi. 10.1002/hed.23046
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1575, doi. 10.1007/s10637-011-9732-3
- By:
- Publication type:
- Article
Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 3, p. 722, doi. 10.1245/s10434-011-2087-3
- By:
- Publication type:
- Article
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 15, p. 3374, doi. 10.1002/cncr.25852
- By:
- Publication type:
- Article
Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy.
- Published in:
- Head & Neck, 2011, v. 33, n. 3, p. 318, doi. 10.1002/hed.21444
- By:
- Publication type:
- Article
Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 33, doi. 10.3816/CLC.2011.n.004
- By:
- Publication type:
- Article
The Impact of Health Insurance Status on the Survival of Patients With Head and Neck Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 2, p. 476, doi. 10.1002/cncr.24774
- By:
- Publication type:
- Article
Management of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: The University of Pittsburgh experience.
- Published in:
- Laryngoscope, 2010, v. 120, n. 1, p. 71, doi. 10.1002/lary.20697
- By:
- Publication type:
- Article
Docetaxel and Irinotecan in Recurrent or Metastatic Head and Neck Cancer: A Phase 2 Trial of the Eastern Cooperative Oncology Group.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 19, p. 4504, doi. 10.1002/cncr.24528
- By:
- Publication type:
- Article
Evaluating the Supportive Care Costs of Severe Radiochemotherapy-Induced Mucositis and Pharyngitis.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 6, p. 1446, doi. 10.1002/cncr.23714
- By:
- Publication type:
- Article
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 183, doi. 10.1007/s10637-007-9091-2
- By:
- Publication type:
- Article
Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer.
- Published in:
- Laryngoscope, 2008, v. 118, n. 3, p. 444, doi. 10.1097/MLG.0b013e31815b48f4
- By:
- Publication type:
- Article
Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Deferring Planned Neck Dissection Following Chemoradiation for Stage IV Head and Neck Cancer: The Utility of PET-CT.
- Published in:
- Laryngoscope, 2007, v. 117, n. 12, p. 2129, doi. 10.1097/MLG.0b013e318149e6bc
- By:
- Publication type:
- Article
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 1, p. 70, doi. 10.1001/jama.298.1.70
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of docetaxel, irinotecan, and celecoxib in patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2006, v. 24, n. 3, p. 203, doi. 10.1007/s10637-005-3259-4
- By:
- Publication type:
- Article
Revisiting Induction Chemotherapy for Head and Neck Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 7, p. 932
- By:
- Publication type:
- Article
Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neckThe current study was conducted by the Eastern Oncology Cooperative Group (Robert L. Comis, M.D., Chair).: An analysis of two Eastern Cooperative Oncology Group randomized trials
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 10, p. 2222
- By:
- Publication type:
- Article
Can current treatments for advanced non-small-cell lung cancer be improved?
- Published in:
- 2004
- By:
- Publication type:
- commentary
Esthesioneuroblastoma: The Northwestern University Experience.
- Published in:
- Laryngoscope, 2003, v. 113, n. 1, p. 155, doi. 10.1097/00005537-200301000-00029
- By:
- Publication type:
- Article
Abnormalities of Serum Amylase and Lipase in HIV-Positive Patients.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1999, v. 94, n. 5, p. 1248, doi. 10.1111/j.1572-0241.1999.01074.x
- By:
- Publication type:
- Article